Oertle T - Search Results

1

Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats.

Wiessner C, Bareyre FM, Allegrini PR, Mir AK, Frentzel S, Zurini M, Schnell L, Oertle T, Schwab ME. Wiessner C, et al. Among authors: oertle t. J Cereb Blood Flow Metab. 2003 Feb;23(2):154-65. doi: 10.1097/01.WCB.0000040400.30600.AF. J Cereb Blood Flow Metab. 2003. PMID: 12571447

2

Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions.

Huber AB, Weinmann O, Brösamle C, Oertle T, Schwab ME. Huber AB, et al. Among authors: oertle t. J Neurosci. 2002 May 1;22(9):3553-67. doi: 10.1523/JNEUROSCI.22-09-03553.2002. J Neurosci. 2002. PMID: 11978832 Free PMC article.

3

Do cancer cells die because of Nogo-B?

Oertle T, Merkler D, Schwab ME. Oertle T, et al. Oncogene. 2003 Mar 6;22(9):1390-9. doi: 10.1038/sj.onc.1206278. Oncogene. 2003. PMID: 12618765

4

Nogo and its paRTNers.

Oertle T, Schwab ME. Oertle T, et al. Trends Cell Biol. 2003 Apr;13(4):187-94. doi: 10.1016/s0962-8924(03)00035-7. Trends Cell Biol. 2003. PMID: 12667756 Review.

5

Rapid induction of autoantibodies against Nogo-A and MOG in the absence of an encephalitogenic T cell response: implication for immunotherapeutic approaches in neurological diseases.

Merkler D, Oertle T, Buss A, Pinschewer DD, Schnell L, Bareyre FM, Kerschensteiner M, Buddeberg BS, Schwab ME. Merkler D, et al. Among authors: oertle t. FASEB J. 2003 Dec;17(15):2275-7. doi: 10.1096/fj.02-1203fje. Epub 2003 Oct 16. FASEB J. 2003. PMID: 14563689

6

Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions.

Oertle T, van der Haar ME, Bandtlow CE, Robeva A, Burfeind P, Buss A, Huber AB, Simonen M, Schnell L, Brösamle C, Kaupmann K, Vallon R, Schwab ME. Oertle T, et al. J Neurosci. 2003 Jul 2;23(13):5393-406. doi: 10.1523/JNEUROSCI.23-13-05393.2003. J Neurosci. 2003. PMID: 12843238 Free PMC article.

7

Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4.

Oertle T, Huber C, van der Putten H, Schwab ME. Oertle T, et al. J Mol Biol. 2003 Jan 10;325(2):299-323. doi: 10.1016/s0022-2836(02)01179-8. J Mol Biol. 2003. PMID: 12488097

8

A reticular rhapsody: phylogenic evolution and nomenclature of the RTN/Nogo gene family.

Oertle T, Klinger M, Stuermer CA, Schwab ME. Oertle T, et al. FASEB J. 2003 Jul;17(10):1238-47. doi: 10.1096/fj.02-1166hyp. FASEB J. 2003. PMID: 12832288

9

Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA.

Schweigreiter R, Walmsley AR, Niederöst B, Zimmermann DR, Oertle T, Casademunt E, Frentzel S, Dechant G, Mir A, Bandtlow CE. Schweigreiter R, et al. Among authors: oertle t. Mol Cell Neurosci. 2004 Oct;27(2):163-74. doi: 10.1016/j.mcn.2004.06.004. Mol Cell Neurosci. 2004. PMID: 15485772

10

Identification of Nogo-66 receptor (NgR) and homologous genes in fish.

Klinger M, Taylor JS, Oertle T, Schwab ME, Stuermer CA, Diekmann H. Klinger M, et al. Among authors: oertle t. Mol Biol Evol. 2004 Jan;21(1):76-85. doi: 10.1093/molbev/msg241. Epub 2003 Aug 29. Mol Biol Evol. 2004. PMID: 12949137

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters